153 related articles for article (PubMed ID: 12228184)
1. Flavin-containing monooxygenase activity in hepatocytes and microsomes: in vitro characterization and in vivo scaling of benzydamine clearance.
Fisher MB; Yoon K; Vaughn ML; Strelevitz TJ; Foti RS
Drug Metab Dispos; 2002 Oct; 30(10):1087-93. PubMed ID: 12228184
[TBL] [Abstract][Full Text] [Related]
2. Benzydamine N-oxygenation as an index for flavin-containing monooxygenase activity and benzydamine N-demethylation by cytochrome P450 enzymes in liver microsomes from rats, dogs, monkeys, and humans.
Taniguchi-Takizawa T; Shimizu M; Kume T; Yamazaki H
Drug Metab Pharmacokinet; 2015 Feb; 30(1):64-9. PubMed ID: 25760531
[TBL] [Abstract][Full Text] [Related]
3. Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity.
Störmer E; Roots I; Brockmöller J
Br J Clin Pharmacol; 2000 Dec; 50(6):553-61. PubMed ID: 11136294
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms.
Lang DH; Rettie AE
Br J Clin Pharmacol; 2000 Oct; 50(4):311-4. PubMed ID: 11012553
[TBL] [Abstract][Full Text] [Related]
5. Drug oxygenation activities mediated by liver microsomal flavin-containing monooxygenases 1 and 3 in humans, monkeys, rats, and minipigs.
Yamazaki M; Shimizu M; Uno Y; Yamazaki H
Biochem Pharmacol; 2014 Jul; 90(2):159-65. PubMed ID: 24821112
[TBL] [Abstract][Full Text] [Related]
6. Benzydamine N-oxygenation as a measure of flavin-containing monooxygenase activity.
Yeung CK; Rettie AE
Methods Mol Biol; 2006; 320():157-62. PubMed ID: 16719388
[TBL] [Abstract][Full Text] [Related]
7. Functional assessment of rat pulmonary flavin-containing monooxygenase activity.
Yilmaz Y; Williams G; Manevski N; Walles M; Krähenbühl S; Camenisch G
Xenobiotica; 2019 May; 49(5):503-512. PubMed ID: 29694257
[TBL] [Abstract][Full Text] [Related]
8. Estimation of flavin-containing monooxygenase activity in intact hepatocyte monolayers of rat, hamster, rabbit, dog and human by using N-oxidation of benzydamine.
Ubeaud G; Schiller CD; Hurbin F; Jaeck D; Coassolo P
Eur J Pharm Sci; 1999 Aug; 8(4):255-60. PubMed ID: 10425375
[TBL] [Abstract][Full Text] [Related]
9. An assay of flavin-containing monooxygenase activity with benzydamine N-oxidation.
Kawaji A; Ohara K; Takabatake E
Anal Biochem; 1993 Nov; 214(2):409-12. PubMed ID: 8109727
[TBL] [Abstract][Full Text] [Related]
10. Flavin-containing monooxygenase mediated metabolism of benzydamine in perfused brain and liver.
Kawaji A; Isobe M; Tochino Y; Takabatake E; Chikaoka Y; Nomura Y; Tamura M
Biochim Biophys Acta; 1998 Sep; 1425(1):41-6. PubMed ID: 9813235
[TBL] [Abstract][Full Text] [Related]
11. Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase.
Uehara S; Shimizu M; Uno Y; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2017 May; 45(5):497-500. PubMed ID: 28258069
[TBL] [Abstract][Full Text] [Related]
12. Determination of flavin-containing monooxygenase activity in rat brain microsomes with benzydamine N-oxidation.
Kawaji A; Ohara K; Takabatake E
Biol Pharm Bull; 1994 May; 17(5):603-6. PubMed ID: 7920416
[TBL] [Abstract][Full Text] [Related]
13. Benzydamine as a useful substrate of hepatic flavin-containing monooxygenase activity in veterinary species.
Capolongo F; Santi A; Anfossi P; Montesissa C
J Vet Pharmacol Ther; 2010 Aug; 33(4):341-6. PubMed ID: 20646194
[TBL] [Abstract][Full Text] [Related]
14. An Investigation into the Prediction of the Plasma Concentration-Time Profile and Its Interindividual Variability for a Range of Flavin-Containing Monooxygenase Substrates Using a Physiologically Based Pharmacokinetic Modeling Approach.
Reddy VP; Jones BC; Colclough N; Srivastava A; Wilson J; Li D
Drug Metab Dispos; 2018 Sep; 46(9):1259-1267. PubMed ID: 29895591
[TBL] [Abstract][Full Text] [Related]
15. In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.
Rodrigues AD; Kukulka MJ; Ferrero JL; Cashman JR
Drug Metab Dispos; 1995 Oct; 23(10):1143-52. PubMed ID: 8654204
[TBL] [Abstract][Full Text] [Related]
16. Potential for drug interactions mediated by polymorphic flavin-containing monooxygenase 3 in human livers.
Shimizu M; Shiraishi A; Sato A; Nagashima S; Yamazaki H
Drug Metab Pharmacokinet; 2015 Feb; 30(1):70-4. PubMed ID: 25760532
[TBL] [Abstract][Full Text] [Related]
17. Species Differences in the Oxidative Desulfurization of a Thiouracil-Based Irreversible Myeloperoxidase Inactivator by Flavin-Containing Monooxygenase Enzymes.
Eng H; Sharma R; Wolford A; Di L; Ruggeri RB; Buckbinder L; Conn EL; Dalvie DK; Kalgutkar AS
Drug Metab Dispos; 2016 Aug; 44(8):1262-9. PubMed ID: 27079250
[TBL] [Abstract][Full Text] [Related]
18. In vitro hepatic metabolism of cediranib, a potent vascular endothelial growth factor tyrosine kinase inhibitor: interspecies comparison and human enzymology.
Schulz-Utermoehl T; Spear M; Pollard CR; Pattison C; Rollison H; Sarda S; Ward M; Bushby N; Jordan A; Harrison M
Drug Metab Dispos; 2010 Oct; 38(10):1688-97. PubMed ID: 20634336
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
Mani C; Hodgson E; Kupfer D
Drug Metab Dispos; 1993; 21(4):657-61. PubMed ID: 8104125
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.
Nishimuta H; Watanabe T; Bando K
AAPS J; 2019 Jan; 21(2):20. PubMed ID: 30673906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
